0001683168-22-000276.txt : 20220114 0001683168-22-000276.hdr.sgml : 20220114 20220114203213 ACCESSION NUMBER: 0001683168-22-000276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220114 FILED AS OF DATE: 20220114 DATE AS OF CHANGE: 20220114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DVONCH JEROME J CENTRAL INDEX KEY: 0001518735 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33216 FILM NUMBER: 22533304 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001367083 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680423298 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 645 MOLLY LANE, SUITE 150 CITY: WOODSTOCK STATE: GA ZIP: 30189 BUSINESS PHONE: 800-759-9305 MAIL ADDRESS: STREET 1: 645 MOLLY LANE, SUITE 150 CITY: WOODSTOCK STATE: GA ZIP: 30189 FORMER COMPANY: FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc. DATE OF NAME CHANGE: 20060622 4 1 ownership.xml X0306 4 2022-01-14 0 0001367083 Sonoma Pharmaceuticals, Inc. SNOA 0001518735 DVONCH JEROME J C/O SONOMA PHARMACEUTICALS, INC. 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 0 1 0 0 Chief Financial Officer Stock option (right to buy) 4.6 2022-01-14 4 A 0 30000 A 2032-01-14 Common stock 30000 57777 D The options vest 10,000 options each on 07/14/2022, 07/14/2023, 07/14/2024 and or upon a change of control. The options were awarded and granted to Mr. Dvonch for services performed. /s/ Amy Trombly (Attorney in fact) 2022-01-14